
Kwality Pharma Acquires 4 Acres for Amritsar Expansion
Kwality Pharmaceuticals Limited has acquired 4 acres of land adjacent to its existing manufacturing facility in Amritsar, Punjab. This expansion is intended to support the company's next phase of growth by developing a new, fully automated manufacturing facility. The proposed facility will include 4 injectable lines and over 6 lines for various oral solid dosage formulations, designed to meet EU GMP standards. The expansion aims to cater to increasing demand, accommodate future product launches and bioequivalence opportunities, and enhance the Amritsar manufacturing campus. Project completion is targeted for Q4 FY2028, with full operations expected by Q2 FY2029.
Key Highlights
- Acquired 4 acres of land for manufacturing expansion in Amritsar.
- New facility to include 4 injectable lines and 6+ oral solid dosage lines.
- Expansion aims to meet growing demand and support future product launches.
- Project completion targeted for Q4 FY2028, operations by Q2 FY2029.
Price Impact
More from KPL
Kwality Pharmaceuticals Closes Trading Window for Insider Trading
Kwality Pharma Declares Q1 FY27 Unaudited Financial Results
Kwality Pharma Q1FY27: consolidated PAT surges 115% YoY to ₹25.6 Cr, margins expand, guidance raised